Examples of 'hyperphosphatemia' in a sentence
Meaning of "hyperphosphatemia"
hyperphosphatemia - a medical condition characterized by an elevated level of phosphate in the blood
Show more definitions
- An elevated amount of phosphate in the blood
How to use "hyperphosphatemia" in a sentence
Basic
Advanced
hyperphosphatemia
Hyperphosphatemia is directly related to mortality and morbidity.
Blood phosphate level above normal hyperphosphatemia.
Hyperphosphatemia results from massive release of intracellular phosphate.
Prophylactic benefit includes prevention or delay of hyperphosphatemia.
Hyperphosphatemia and vascular calcification.
Secondary outcomes of hypertension and hyperphosphatemia were also improved.
Hyperphosphatemia in chronic renal failure.
One example of a phosphate imbalance disorder includes hyperphosphatemia.
Direct effect of hyperphosphatemia on calcification.
Hyperphosphatemia has been classically linked to the pathogenesis of secondary hyperparathyroidism sHPT.
It may also occur with hyperphosphatemia.
Hyperphosphatemia is when you have too much phosphate in your blood.
The guideline further recommends managing hyperphosphatemia by remedy as a priority.
They are also used in hypoparathyroidism which presents with hypocalcemia with hyperphosphatemia.
Treatment of hyperphosphatemia.
See also
The effects may appear mainly when hypercalcemia is accompanied by hyperphosphatemia.
Current treatments for hyperphosphatemia do not address the issue of metabolic acidosis.
Additionally there was no difference in incidence of hypercalcemia or hyperphosphatemia when compared to placebo.
The clinical manifestations of hyperphosphatemia are varied and have considerable mortality risks.
The methods disclosed here can be used to attenuate or prevent hyperphosphatemia.
Hyperphosphatemia and metabolic acidosis frequently accompanies diseases associated with inadequate renal function.
The methods of the invention involve treatment of patients with hyperphosphatemia.
Several studies have associated hyperphosphatemia with VC and vascular disease.
One of the major clinical problems with renal failure patients is hyperphosphatemia.
A detailed discussion of Pi homeostasis and hyperphosphatemia treatment can be found elsewhere.
The phosphate binders disclosed herein may be employed for the treatment of hyperphosphatemia.
A person with an underlying condition linked to hyperphosphatemia may wish to avoid these foods.
Many patients present a combination of calcium overload arising from hemodialysis or drug therapy and hyperphosphatemia.
Patients who develop marked hypercalcemia or marked hyperphosphatemia immediately suspend treatment.
The method in accordance with the present invention has significantly less resultant hypercalcemia and hyperphosphatemia.
Hyperphosphatemia is common, associated with increased renal phosphate reabsorption.
Rats with CKD were protected from hyperplasia by hyperphosphatemia.
The mechanism ( s ) underlying the hyperphosphatemia of lactic acidosis is uncertain.
Use The objects of the invention involve treatment of patients with hyperphosphatemia.
Treatment for hyperphosphatemia will depend on the underlying cause,.
With this progress, the model developed hyperphosphatemia.
Severe hyperphosphatemia can cause paralysis, convulsions and cardiac arrest.
The incidence of hypercalcemia . hypercalciuria and hyperphosphatemia are substantial.
In this regard, hyperphosphatemia becomes a very significant problem in clinical practice.
Renal osteodystrophy, accompanied by hyperphosphatemia.
The mechanism ( s ) for the hyperphosphatemia associated with lactic acidosis is unknown.
Therefore, their phosphorus concentrations in blood are elevated to cause hyperphosphatemia.
Hyperphosphatemia inhibits renal synthesis of calcitriol, which causes an exacerbation of the hypocalcemia condition.
Phosphorus imbalance, however, does not necessarily equate with hyperphosphatemia.
For example, in a hyperphosphatemia patient, therapeutic benefit includes eradication or amelioration of the underlying hyperphosphatemia.
In one aspect, a method is disclosed for treatment of hyperphosphatemia in hemodialysis patients.
In a subject having hyperphosphatemia, a beneficial therapeutic outcome includes amelioration or eradication of the underlying hyperphosphatemia.
This is characterized by a persistent reduced release of parathormone, followed by hypocalcemia and hyperphosphatemia.
The incidence of hypercalcemia, hypercalciuria and hyperphosphatemia are rare once stable dosing has been achieved.
However, more research is needed before niacinamide can be used to treat hyperphosphatemia.
